Recapitulation of the embryonic cardiovascular progenitor cell niche

Biomaterials

Volumn 32, Issue 11, 2011, Pages 2748-2756

  Schenke Layland, Katja ^a,b,c   Nsair, Ali ^c   Van Handel, Ben ^d   Angelis, Ekaterini ^c   Gluck, Jessica M ^c   Votteler, Miriam ^a,b   Goldhaber, Joshua I ^e   Mikkola, Hanna K ^d   Kahn, Michael ^f,g   MacLellan, William R ^c,d  

^a FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiac tissue engineering; Extracellular matrix; Heart; Scaffold; Stem cell

Indexed keywords

CARDIAC TISSUE ENGINEERING; CELL FATE DECISION; CONTROL CULTURES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEIN; IN-VITRO; IN-VIVO; INNOVATIVE APPROACHES; MICROENVIRONMENTS; MOUSE EMBRYONIC STEM CELLS; MOUSE HEART; PROGENITOR CELL; SIGNALING PATHWAYS; SMALL MOLECULES; THREE DIMENSIONAL (3D) STRUCTURES;

CELL CULTURE; CELL PROLIFERATION; ENZYME ACTIVITY; EXPANSION; HEART; SCAFFOLDS; SIGNALING; THREE DIMENSIONAL; TISSUE; TISSUE ENGINEERING;

STEM CELLS;

BETA CATENIN; COLLAGEN TYPE 4; PROTEIN P300; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CARDIOVASCULAR PROGENITOR CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL FATE; CELL STRUCTURE; CONTROLLED STUDY; ELECTROSPINNING; EMBRYO; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL NICHE;

ANIMALS; BETA CATENIN; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEART; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, CONFOCAL; PREGNANCY;

EID: 79951577787     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.046     Document Type: Article

References (35)

1. Kattman S.J., Huber T.L., Keller G.M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006, 11:723-732.
2. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433:647-653.
3. Moretti A., Caron L., Nakano A., Lam J.T., Bernshausen A., Chen Y., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
4. Wu S.M., Fujiwara Y., Cibulsky S.M., Clapham D.E., Lien C.L., Schultheiss T.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006, 127:1137-1150.
5. Schenke-Layland K., Rhodes K.E., Angelis E., Butylkova Y., Heydarkhan-Hagvall S., Gekas C., et al. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 2008, 26:1537-1546.
6. Bu L., Jiang X., Martin-Puig S., Caron L., Zhu S., Shao Y., et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009, 460:113-117.
7. Fuchs E., Tumbar T., Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004, 116:769-778.
8. Votteler M., Kluger P., Walles W., Schenke-Layland K. Stem cell microenvironments-unveiling the secret of how stem cell fate is defined. Macromol Biosci 2010, 10:1302-1315.
9. Watt F.M., Hogan B.L. Out of Eden: stem cells and their niches. Science 2000, 287:1427-1430.
10. Urbanek K., Cesselli D., Rota M., Nascimbene A., De Angelis A., Hosoda T., et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A 2006, 103:9226-9231.
11. Cohen E.D., Tian Y., Morrisey E.E. Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 2008, 135:789-798.
12. Qyang Y., Martin-Puig S., Chiravuri M., Chen S., Xu H., Bu L., et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell. 2007, 1:165-179.
13. Lin L., Cui L., Zhou W., Dufort D., Zhang X., Cai C.L., et al. Beta-catenin directly regulates Islet1 expression in cardiovascular progenitors and is required for multiple aspects of cardiogenesis. Proc Natl Acad Sci U S A 2007, 104:9313-9318.
14. Cohen E.D., Wang Z., Lepore J.J., Lu M.M., Taketo M.M., Epstein D.J., et al. Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest 2007, 117:1794-1804.
15. Nusse R. Wnt signaling and stem cell control. Cell Res 2008, 18:523-527.
16. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007, 87:1285-1342.
17. Leri A., Kajstura J., Anversa P., Frishman W.H. Myocardial regeneration and stem cell repair. Curr Probl Cardiol 2008, 33:91-153.
18. Rodriguez-Feo J.A., Sluijter J.P., de Kleijn D.P., Pasterkamp G. Modulation of collagen turnover in cardiovascular disease. Curr Pharm Des 2005, 11:2501-2514.
19. Daley W.P., Peters S.B., Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 2008, 121:255-264.
20. Schenke-Layland K., Angelis E., Rhodes K.E., Heydarkhan-Hagvall S., Mikkola H.K., Maclellan W.R. Collagen IV induces trophoectoderm differentiation of mouse embryonic stem cells. Stem Cells 2007, 25:1529-1538.
21. Hakuno D., Takahashi T., Lammerding J., Lee R.T. Focal adhesion kinase signaling regulates cardiogenesis of embryonic stem cells. J Biol Chem 2005, 280:39534-39544.
22. Miyabayashi T., Teo J.L., Yamamoto M., McMillan M., Nguyen C., Kahn M. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A 2007, 104:5668-5673.
23. Schenke-Layland K., Xie J., Magnusson M., Angelis E., Li X., Wu K., et al. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjogren's syndrome-like exocrinopathy. Exp Eye Res 2010, 90:223-237.
24. Schenke-Layland K., Rofail F., Heydarkhan S., Gluck J.M., Ingle N.P., Angelis E., et al. The use of three-dimensional nanostructures to instruct cells to produce extracellular matrix for regenerative medicine strategies. Biomaterials 2009, 30:4665-4675.
25. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
26. Teo J.L., Kahn M. The Wnt signaling pathway in cellular proliferation and differentiation: a tale of two coactivators. Adv Drug Deliv Rev 2010, 62:1149-1155.
27. McCloskey K.E., Stice S.L., Nerem R.M. In vitro derivation and expansion of endothelial cells from embryonic stem cells. Methods Mol Biol 2006, 330:287-301.
28. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
29. Badylak S.F., Nerem R.M. Progress in tissue engineering and regenerative medicine. Proc Natl Acad Sci U S A 2010, 107:3285-3286.
30. Lund A.W., Stegemann J.P., Plopper G.E. Inhibition of ERK promotes collagen gel compaction and fibrillogenesis to amplify the osteogenesis of human mesenchymal stem cells in three-dimensional collagen I culture. Stem Cells Dev 2009, 18:331-341.
31. Rabbany S.Y., James D., Rafii S. New dimensions in vascular engineering: opportunities for cancer biology. Tissue Eng Part A 2010, 16:2157-2159.
32. Tate C.C., Shear D.A., Tate M.C., Archer D.R., Stein D.G., LaPlaca M.C. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J Tissue Eng Regen Med 2009, 3:208-217.
33. Vorotnikova E., McIntosh D., Dewilde A., Zhang J., Reing J.E., Zhang L., et al. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo. Matrix Biol 2010, 29:690-700.
34. Krause D.S. Regulation of hematopoietic stem cell fate. Oncogene 2002, 21:3262-3269.
35. Hochedlinger K., Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009, 136:509-523.